4
Changes in Ownership
Amphastar Pharmaceuticals, Inc. Filed Acc 0001104659-21-025361
CEO & Chief Scientific Officer sold 30,467 shares at an average $18.59 ($566,315)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Zhang Jack Y. CEO & Chief Scientific Officer | 2021-02-16 | Sale | −16,259 | $18.51 | $301,031 | 6,841,887 | I |
| Zhang Jack Y. CEO & Chief Scientific Officer | 2021-02-17 | Sale | −13,801 | $18.67 | $257,723 | 6,828,086 | I |
| Zhang Jack Y. CEO & Chief Scientific Officer | 2021-02-18 | Sale | −407 | $18.58 | $7,562 | 6,827,679 | I |
| Open-market sales · 30,467 sh · avg $18.59 · $566,315 | |||||||
Loading xslF345X03/a4.xml…